SCRIPT team present poster at RCN Education Forum Conference 2025

1st March 2025

The SCRIPT team was delighted to present a poster at the RCN Education Forum Conference 2025 held in Glasgow, showcasing the new SCRIPT Prescriber Ready portfolio. 

The conference provided a great opportunity to demonstrate SCRIPT Prescriber Ready as a valuable eLearning resource for undergraduate nurses. It also facilitated discussions around the use of accessible technology in nursing education with healthcare professionals and nursing educators.

Reference: 

KAUR, H., et al. 2025. SCRIPT Prescriber Ready: An accessible eLearning portfolio to improve pharmacology knowledge for nurses preparing for independent prescribing. RCN Education Forum National Conference and Exhibition. Glasgow, UK. (Poster presentation). 

More News

SCRIPT eLearning Shortlisted for Prestigious HSJ Patient Safety Award

SCRIPT eLearning is delighted to announce that it has been shortlisted in the ‘Patient Safety Education and Training’ category of the HSJ Patient Safety Awards 2026, recognising its ongoing contribution to improving safety in prescribing and medicines management. The...

Birmingham Education for Health Professional Conference 2026

The SCRIPT team was delighted to present a poster at the Birmingham Education for Health Professional Conference 2026, led by our Research Associate Divya Singh. The poster, titled "eLearning in Multidisciplinary Prescribing Education: A Longitudinal Evaluation...

New Modules Under Development

We are committed to developing and adding new modules to ensure the SCRIPT programme continues to reflect current clinical practice and meets our learners’ changing needs. We have several modules at various stages of development, including Drugs of Addiction and...

Updated module – Diabetes: Antihyperglycaemic Medicines

NICE has recently updated its guidance on ‘Type 2 diabetes in adults: management’. In a change to national guidance modified‑release metformin alongside an SGLT2 inhibitor is now recommended as first‑line treatment for adults with type 2 diabetes mellitus....